Skip to main content

Month: September 2020

MVC Capital Announces Third Quarter 2020 Results

PURCHASE, N.Y., Sept. 09, 2020 (GLOBE NEWSWIRE) — MVC Capital, Inc. (NYSE: MVC) (“MVC Capital” or the “Company”), a publicly traded business development company (BDC) that makes private debt and equity investments, announced its financial results for the fiscal third quarter ended July 31, 2020.Financial ResultsFor the third quarter of fiscal 2020, the Company earned interest income of $5.6 million and fee and other income of $0.2 million, compared to $7.2 million and $0.3 million, respectively, for the same quarter of fiscal 2019.The Company reported total operating income of $5.8 million for the third quarter of fiscal 2020, compared to $7.5 million for the same quarter in fiscal 2019. The Company reported net operating income of $0.9 million for the third quarter of fiscal 2020 compared to $2.8 million for the same quarter in...

Continue reading

CORRECTION – SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S. 

24.5 Million Covered Lives Now Eligible for Biologic Advanced Wound Care Treatment Through Centene CorporationSUWANEE, GA, Sept. 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin, musculoskeletal tissue and vascular structures, announced today that Centene Corporation, the largest Medicare and Medicaid Administrator in the U.S., has included BIOVANCE® in its list of reimbursed skin substitutes for advanced wound healing for the more than 24.5 million lives it covers. SANUWAVE, through its recent agreement with Cellularity, Inc., is the exclusive distributor for BIOVANCE in the U.S. wound care market. BIOVANCE is decellularized, dehydrated...

Continue reading

Alpine Income Property Trust, Inc. Announces 100% September Rent Collection

DAYTONA BEACH, Fla., Sept. 09, 2020 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) announced that it has collected 100% of the contractual base rents for September 2020. Contractual base rents are those owed to PINE per the current lease agreements.  PINE had previously agreed to defer or abate certain contractual base rents in exchange for additional lease term or other lease enhancing additions that equated to 4.9% of contractual rents. Additionally, the portfolio remains 100% occupied.About Alpine Income Property Trust, Inc.Alpine Income Property Trust, Inc. is a publicly traded real estate investment trust that acquires, owns and operates a portfolio of high-quality single-tenant net leased commercial income properties.We encourage you to visit our website at www.alpinereit.com.Safe...

Continue reading

Streamline Health® Reports Second Quarter 2020 Revenues of $2.9 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.4 million)

Total First Half Fiscal 2020 Revenues of $5.7 million; $2.5 million Net Income; Adjusted EBITDA ($1.0 million)Atlanta, GA, Sept. 09, 2020 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced financial results for the second quarter and first half of fiscal 2020, which ended July 31, 2020.Total revenues for the second quarter of fiscal 2020 were $2.9 million, an increase of approximately 16% compared to $2.5 million in the prior year period. SaaS revenue was up $254,000, or 46%, over the same quarter a year ago. The revenue growth during the period was primarily attributable to higher perpetual revenue and new eValuator customers offset by lower professional...

Continue reading

Canadian Palladium Announces $3 Million Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — Canadian Palladium Resources Inc. (formerly 21C Metals Inc.) (“Canadian Palladium” or the “Company”) (CSE: BULL) (FRA: DCR1) (OTCQB: DCNNF) is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital, acting as agent for the Company, has agreed to offer for sale a combination of units (the “Units”) and flow-through common shares (the “FT Shares”) of the Company on a “best efforts” private placement basis, for aggregate gross proceeds of up to $3,000,019.50, subject to all required regulatory approvals. Up to 8,333,400 Units will be offered at an offering price of $0.12 per Unit; up to 14,814,900 FT Shares will be offered...

Continue reading

Spero Therapeutics Announces Proposed Public Offering

CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multidrug-resistant (MDR) bacterial infections and rare diseases, today announced that it has commenced an underwritten public offering of 8,000,000 shares of common stock in the aggregate, consisting of an offering of shares of common stock (the “common stock offering”) and shares of non-voting Series D Convertible Preferred Stock with each share of Series D Convertible Preferred Stock being convertible into 1,000 shares of common stock. All of the securities in the offering will be sold by Spero. In addition, Spero expects to grant the underwriters in the common stock offering a 30-day...

Continue reading

YRC Worldwide Provides Quarter-To-Date Operating Data for Third Quarter 2020

OVERLAND PARK, Kan., Sept. 09, 2020 (GLOBE NEWSWIRE) — YRC Worldwide Inc. (NASDAQ: YRCW) reported certain operating metrics for the first two months of third quarter 2020.For YRC Worldwide less-than-truckload (LTL), the percent change 2020 from 2019:About YRC WorldwideYRC Worldwide Inc., headquartered in Overland Park, Kan., is the holding company for a portfolio of less-than-truckload (LTL) companies including Holland, New Penn, Reddaway, and YRC Freight, as well as the logistics company HNRY Logistics. Collectively, YRC Worldwide companies have one of the largest, most comprehensive logistics and LTL networks in North America with local, regional, national and international capabilities. Through their teams of experienced service professionals, YRC Worldwide companies offer industry-leading expertise in flexible supply chain solutions,...

Continue reading

Lands’ End Announces New Term Loan and Expanded ABL Facility

Company Refinances Existing Term Loan debt New Loan Maturity In 2025 Enhances Liquidity and Further Strengthens Balance SheetDODGEVILLE, Wis., Sept. 09, 2020 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that it has secured a new term loan of $275 million.  The loan proceeds, combined with borrowings under the Company’s ABL Facility, were used to refinance the Company’s term loan, which was due in April 2021.  Upon the closing of the refinancing, maximum availability under the ABL Facility was expanded by $75 million to $275 million. “We are pleased to announce the completion of this refinancing, which accomplished several important objectives, including extending our debt duration and further enhancing our strong liquidity position with a more flexible balance sheet,” stated Jim Gooch, Chief Financial Officer...

Continue reading

Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare Conference

BURLINGTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the H.C. Wainwright Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 10:00 a.m. ET on Tuesday, September 15, 2020.  To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s core values are focus, ingenuity,...

Continue reading

Kane Biotech to be Featured in Medtech Webinar Hosted by Alliance Global Partners

WINNIPEG, Manitoba, Sept. 09, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that it will be featured in a live webinar hosted by Ben Haynor, CFA, Managing Director, Healthcare Research at Alliance Global Partners, on September 15, 2020 at 10:30 a.m. Eastern Time.The event will be broadcast live and archived on the Company’s website at www.kanebiotech.com under “News/Events” in the Investors section.About Kane Biotech Inc.Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.